NCT00393523View on ClinicalTrials.gov

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,478

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hepatitis B
Interventions
BIOLOGICAL

Comparator: Modified Process Hepatitis B Vaccine

Single dose 5 µg/0.5ml modified process hepatitis B vaccine

BIOLOGICAL

Comparator: Comparator: ENGERIX-B

Single dose 10 µg/0.5ml ENGERIX-B

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00393523 - Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED) | Biotech Hunter | Biotech Hunter